Growth Metrics

Nurix Therapeutics (NRIX) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to $1.5 million.

  • Nurix Therapeutics' Receivables - Other changed 0.0% to $1.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.5 million for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Nurix Therapeutics' Receivables - Other stood at $1.5 million, which was down 0.0% from $1.7 million recorded in Q3 2025.
  • Over the past 5 years, Nurix Therapeutics' Receivables - Other peaked at $7.0 million during Q1 2025, and registered a low of $600000.0 during Q2 2024.
  • In the last 5 years, Nurix Therapeutics' Receivables - Other had a median value of $1.7 million in 2025 and averaged $2.5 million.
  • Per our database at Business Quant, Nurix Therapeutics' Receivables - Other crashed by 8800.0% in 2021 and then soared by 30000.0% in 2023.
  • Nurix Therapeutics' Receivables - Other (Quarter) stood at $900000.0 in 2021, then rose by 11.11% to $1.0 million in 2022, then skyrocketed by 300.0% to $4.0 million in 2023, then tumbled by 62.5% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q4 2025, $1.7 million for Q3 2025, and $1.7 million during Q2 2025.